Rotraut Mössner Selected Research

Arthritis (Polyarthritis)

1/2022	Ansprechen eines mit rheumatoider Arthritis assoziierten Pyoderma gangraenosum auf den JAK1-Inhibitor Upadacitinib.
5/2019	[Gastrointestinal side effects of apremilast : Characterization and management].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rotraut Mössner Research Topics

Disease

23	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 01/2002
6	Psoriatic Arthritis 11/2023 - 06/2007
5	Melanoma (Melanoma, Malignant) 07/2016 - 09/2002
4	Pityriasis Rubra Pilaris 01/2024 - 03/2019
4	Neoplasms (Cancer) 07/2016 - 09/2002
3	Rheumatoid Arthritis 01/2022 - 09/2008
3	Inflammation (Inflammations) 06/2011 - 06/2004
2	Lichen Planus (Lichen Ruber Planus) 01/2022 - 12/2021
2	Pyoderma 01/2022 - 01/2022
2	Arthritis (Polyarthritis) 01/2022 - 05/2019
2	Eosinophilic Fasciitis 12/2021 - 08/2021
2	Acrodermatitis (Gianotti Crosti Syndrome) 10/2021 - 01/2019
2	Multiple Sclerosis 01/2021 - 04/2016
2	Hypersensitivity (Allergy) 01/2011 - 12/2003
1	Erythema 01/2023
1	Hidradenitis Suppurativa 11/2022
1	Localized Scleroderma (Morphea) 12/2021
1	Body Weight (Weight, Body) 12/2021
1	Sclerosis 12/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2021
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 08/2021
1	Nicolau Syndrome 01/2021
1	Injection Site Reaction 01/2021
1	Skin Diseases (Skin Disease) 03/2019
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2018
1	Ankylosing Spondylitis 01/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Chronic Mucocutaneous Candidiasis 04/2016
1	Granuloma Annulare 03/2016
1	Necrosis 01/2011
1	Contact Dermatitis (Eczema, Contact) 01/2011

Drug/Important Bio-Agent (IBA)

6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2002
5	Methotrexate (Mexate)FDA LinkGeneric 11/2023 - 11/2012
5	Infliximab (Remicade)FDA Link 01/2018 - 03/2008
5	Proteins (Proteins, Gene)FDA Link 07/2012 - 09/2002
4	Adalimumab (Humira)FDA Link 01/2018 - 09/2008
4	Etanercept (Enbrel)FDA Link 01/2018 - 09/2008
3	upadacitinibIBA 01/2022 - 12/2021
3	risankizumabIBA 08/2021 - 10/2020
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 04/2016
3	Tumor Necrosis Factor InhibitorsIBA 01/2009 - 03/2008
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2007 - 09/2002
2	bimekizumabIBA 01/2024 - 12/2023
2	apremilastIBA 01/2023 - 05/2019
2	Interleukin-23 (Interleukin 23)IBA 10/2021 - 02/2009
2	InterleukinsIBA 07/2018 - 01/2002
2	AntibodiesIBA 07/2016 - 09/2008
2	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2011 - 01/2007
2	Interleukin-16 (Interleukin 16)IBA 01/2011 - 12/2003
2	PPAR gammaIBA 02/2007 - 09/2002
2	PPAR alphaIBA 06/2004 - 09/2002
2	LigandsIBA 06/2004 - 09/2002
2	CytokinesIBA 12/2003 - 01/2002
1	Immunoglobulin A (IgA)IBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	tofacitinibIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021
1	GlucocorticoidsIBA 12/2021
1	Prednisolone (Predate)FDA LinkGeneric 08/2021
1	Rituximab (Mabthera)FDA Link 08/2021
1	Glatiramer Acetate (Copaxone)FDA Link 01/2021
1	guselkumabIBA 11/2020
1	tildrakizumabIBA 11/2020
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2019
1	brodalumabIBA 05/2019
1	Interleukin-17 ReceptorsIBA 05/2019
1	Isotretinoin (Accutane)FDA LinkGeneric 03/2019
1	Lipocalin-2IBA 04/2018
1	AfatinibIBA 02/2018
1	Ustekinumab (CNTO 1275)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 07/2016
1	Immune Checkpoint InhibitorsIBA 07/2016
1	ruxolitinibIBA 04/2016
1	Interferon-betaIBA 04/2016
1	VemurafenibIBA 03/2016
1	Leflunomide (Arava)FDA LinkGeneric 01/2015
1	Acitretin FDA Link 01/2015
1	FumaratesIBA 01/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2015
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 07/2012
1	1,25-dihydroxyvitamin DIBA 07/2012
1	Genetic Markers (Genetic Marker)IBA 07/2012
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2012
1	Vitamin D FDA LinkGeneric 07/2012
1	Vitamin D-Binding ProteinIBA 07/2012
1	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2012
1	Vitamin D3 24-HydroxylaseIBA 07/2012
1	ParaffinIBA 06/2011
1	Anti-Idiotypic AntibodiesIBA 06/2011
1	Formaldehyde (Formol)FDA Link 06/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2011
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2011
1	Filaggrin ProteinsIBA 01/2011
1	Irritants (Vesicants)IBA 01/2011
1	Superoxide DismutaseIBA 01/2011

Therapy/Procedure

10	Therapeutics 11/2023 - 03/2008
1	Aftercare (After-Treatment) 12/2021
1	Intra-Articular Injections 01/2021
1	Subcutaneous Injections 01/2021